0
|
19
|
7pllB |
Structure of the murine cortactin c-sh3 domain in complex with a pyk2 proline-rich ligand |
86
|
274
|
8babA |
Crystal structure of jak2 jh2-v617f in complex with cb76 |
100
|
445
|
8ssnA |
Abl kinase in complex with ski and asciminib |
83
|
273
|
8qelB |
Pkr kinase domain- eif2alpha in complex with compound |
24
|
77
|
8thaA |
1tel, non-compressed, double-helical crystal form |
85
|
289
|
8tb5A |
Tyk2 jh2 bound to compound7 |
90
|
298
|
8tb6A |
Tyk2 jh2 bound to compound14 |
70
|
277
|
8haqA |
The complex of src with gw8510 |
70
|
268
|
8s9fA |
Crystal structure of the kinase domain of bruton's tyrosine kinase bound to dasatinib |
117
|
457
|
8s93A |
Crystal structure of the ph-th/kinase complex of bruton's tyrosine kinase |
87
|
446
|
8gmbA |
Crystal structure of the full-length bruton's tyrosine kinase (ph-th domain not visible) |
87
|
290
|
8s98A |
Crystal structure of the tyk2 pseudokinase domain in complex with compound 8 |
90
|
291
|
8s99A |
Crystal structure of the tyk2 pseudokinase domain in complex with compound 11 |
91
|
292
|
8s9aA |
Crystal structure of the tyk2 pseudokinase domain in complex with tak-279 |
88
|
271
|
8fd9A |
Structure of btk kinase domain with the second-generation inhibitor acalabrutinib |
0
|
5
|
8exkB |
Crystal structure of ptp1b d181a/q262a phosphatase domain with jak2 activation loop phosphopeptide |
0
|
6
|
8eyaD |
Crystal structure of ptp1b d181a/q262a/c215a phosphatase domain with a jak2 activation loop phosphopeptide |
77
|
265
|
8ff0A |
Structure of btk kinase domain with the second-generation inhibitor tirabrutinib |
54
|
145
|
7w8bA |
Crystal structure of human focal adhesion targeting (fat) domain of the focal adhesion kinase |
19
|
179
|
8i9jA |
The pkr and e3l complex |
95
|
289
|
8g8xA |
X-ray co-crystal structure of compound 27 in with complex jak2 |
97
|
289
|
8g8oA |
The crystal structure of jak2 in complex with compound 31 |
100
|
289
|
8g6zA |
Jak2 crystal structure in complex with compound 13 |
93
|
289
|
7teuA |
Crystal structure of jak2 jh1 with type ii inhibitor yliu-04-105-1 |
90
|
275
|
8bi2A |
Syk kinase domain in complex with macrocyclic inhibitor 20a |
85
|
279
|
8bjuA |
Human wee1 kinase in complex with inhibitor 1-[6-(1-hydroxy-1-methyl-ethyl)-pyridin-2-yl]-2-(2-methoxy-phenyl)-6-[4-(4-methyl-piperazin-1-yl)-phenylamino]-1,2-dihydro-pyrazolo[3,4-d]pyrimidin-3-one |
92
|
264
|
7yc9A |
Co-crystal structure of btk kinase domain with inhibitor |
90
|
267
|
8flvA |
Bruton's tyrosine kinase in complex with compound 34 |
84
|
275
|
8fe9A |
Crystal structure of ack1 kinase k161q mutant in complex with the selective inhibitor (r)-9b |
19
|
78
|
8fz3A |
Sterile alpha motif of human translocation ets leukemia, non-polymer crystal form |
77
|
269
|
8h7hA |
The crystal structure of human abl1 kinase domain in complex with abl1-a-eba |
183
|
1122
|
8ewyA |
Structure of janus kinase (jak) dimer complexed with cytokine receptor intracellular domain |
70
|
268
|
8dsoB |
Structure of ciap1, btk and bccov |
91
|
270
|
8ejbA |
Bruton's tyrosine kinase in complex with 3-{[4-(1-acetylpiperidin-4-yl)phenyl]amino}-5-[(3r)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]pyrazine-2-carboxamide |
51
|
153
|
7u4zA |
The ubiquitin-associated domain of human thirty-eight negative kinase-1 flexibly fused to the 1tel crystallization chaperone via a 2-glycine linker and crystallized at very low protein concentration |
40
|
146
|
7u4wA |
The ubiquitin-associated domain of human thirty-eight negative kinase-1 flexibly fused to the 1tel crystallization chaperone via a 2-glycine linker and crystallized at traditional protein concentration |
88
|
264
|
8fllA |
Crystal structure of btk kinase domain in complex with pirtobrutinib |
82
|
269
|
8h7fA |
The crystal structure of human abl1 kinase domain in complex with abl1-b-eba |
84
|
265
|
8flgA |
Bruton's tyrosine kinase in complex with an orthosteric inhibitor |
89
|
263
|
8flnA |
Crystal structure of btk c481s kinase domain in complex with pirtobrutinib |
91
|
267
|
8flhA |
Bruton's tyrosine kinase in complex with an orthosteric inhibitor |
83
|
274
|
7t1tA |
Jak2 jh2 in complex with jak292 |
10
|
56
|
8f2pB |
Nef sf2 dimerization mutant bound to hck sh3 |
88
|
275
|
8ba2A |
Crystal structure of jak2 jh2-v617f in complex with z902-a1 |
86
|
274
|
8b99A |
Crystal structure of jak2 jh2-v617f in complex with jnj-7706621 |
85
|
274
|
8b9eA |
Crystal structure of jak2 jh2-v617f in complex with z902-a3 |
81
|
272
|
8ex1A |
Crystal structure of jak2 jh2 (pseudokinase domain) in complex with reversine |
80
|
273
|
8ex0A |
Crystal structure of jak2 jh2 (pseudokinase domain) in complex with cdk2-iv |
78
|
274
|
8ba4A |
Crystal structure of jak2 jh2-v617f in complex with bemcentinib |
84
|
274
|
8b8uA |
Crystal structure of jak2 jh2-v617f in complex with hts-a3 |